Terveystalo revenue and financials

TTALO · Nasdaq Helsinki · EUR

€7.14Change from previous close: −4.55%Absolute change: −€0.34

Close · October 7, 2026

In the fiscal year ended December 2025, Terveystalo reported revenue of €1.28B (−4.56% year over year). Net income was €92.6M, a net margin of 7.2%.

Annual revenue · 2025: €1.28B
  1. €1.26B2022
  2. €1.29B2023
  3. €1.34B2024
  4. €1.28B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−4.56%
2025 vs 2024
Net income growth
+29.15%
2025 vs 2024
Net margin
7.2%
2024: 5.4%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q2 2025Q1 2025
Total revenue293308330322347
Cost of revenue121124130128138
Gross profit172184200193209
Selling, general and administrative3.63.44.23.03.6
Operating income23.126.732.333.546.5
EBIT22.626.931.833.046.6
EBITDA47.052.260.056.970.4
Interest expense5.45.15.05.35.2
Pre-tax income17.221.826.827.741.4
Income tax3.44.66.05.58.0
Net income13.817.220.822.233.4
Net income to common shareholders13.817.220.822.233.4
Basic EPS0.110.140.160.180.26
Diluted EPS0.110.140.160.170.26
Average shares (basic)127127127127127
Average shares (diluted)127127127131127